Other analysts have also noted that while research and development
spending by pharmaceutical companies has increased dramatically, the number of new drug approvals has remained flat.»
Not exact matches
After adjusting for rebates and other discounts offered
by pharmaceutical companies,
spending totaled $ 309.5 billion, 8.5 % higher than the previous year.
By adding a health insurance
company in the form of Aetna, the resulting combination — retailer, clinic operator, pharmacy benefits manager, and insurer — can realize significant efficiencies, negotiate for lower drug prices with
pharmaceutical manufacturers, and capture the growing share of healthcare
spend among consumers and employers.
«We have
spent millions of dollars to combat the problem through law enforcement, treatment and prevention, and if those efforts have been unfairly impacted
by the improper practices of
pharmaceutical companies and others, we owe it to the tax payers to leave no stone unturned in recovering any unjustified costs.»
Common Cause says the Moreland Commission should open a probe to see if there's a link between around $ 5 million
spent by major
pharmaceutical companies on lobbying and campaign donations to New York state politicians, and the failure to pass major consumer - friendly bills regulating Big Pharma.
Although the
pharmaceutical industry, like the rest of the business world, has suffered a slowdown, the market research
company Frost and Sullivan still expects
spending on drug discovery to expand from US$ 19.6 billion in 2002 to US$ 25.6 billion
by 2006, an annual growth rate of about 6 %.
To make up for these losses, the larger
pharmaceutical companies sought savings
by cutting R&D departments, which traditionally have eaten up a big chunk of the industry's
spending.
The Clinical Research Forum, a consortium of leading academic health centers headed
by Crowley, has asked
pharmaceutical companies for a combined $ 10 million per year for 3 years (the minimum length of time the group expects NIH budget problems to persist), to create «bridging awards» for young investigators who have completed an NIH clinical research training grant, have narrowly missed receiving funding for an independent grant, and are employed at institutions that will match the funding and allow recipients to
spend at least 75 % of their time on research.
That's part of the reason that most drugs that work in animals don't work in people — only 11 % of oncology compounds that show promise in mice are ever approved for humans — despite billions of dollars
spent by pharmaceutical and biotech
companies.
According to a report in 2012
by BMJ, a London based medical journal, for every dollar
pharmaceutical companies spent on «basic research,» they put another $ 19 toward marketing and greasing doctor's palms.